Stay updated on Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing the previous v3.5.3, indicating a new release of the study page.
    Difference
    0.0%
    Check dated 2026-05-15T23:57:45.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The Taiwan location in the study's locations list was updated from Taoyuan District to Taoyuan, Taiwan, 33305. This corrects the geographic designation used for that site in the trial record.
    Difference
    0.0%
    Check dated 2026-05-08T21:49:54.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page’s revision identifier was updated from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-24T06:37:24.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:48:18.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    - Added the disease term 'Squamous cell carcinoma of the head and neck' and introduced a Resources section linking to the Genetic and Rare Diseases Information Center.
    Difference
    0.1%
    Check dated 2026-04-02T15:44:41.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. No user-facing content changes are evident.
    Difference
    0.0%
    Check dated 2026-03-19T06:34:35.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial page.